Durenard Eugene 4
4 · Co-Diagnostics, Inc. · Filed May 27, 2025
Insider Transaction Report
Form 4
Durenard Eugene
Director
Transactions
- Exercise/Conversion
Restricted Stock Unit
2025-05-23−48,334→ 103,333 totalExercise: $0.00→ Common Stock (151,667 underlying) - Award
Common Stock
2025-05-23+48,334→ 211,667 total
Footnotes (1)
- [F1]Included in 70,000 restricted stock units awarded to the Reporting Person on July 7, 2022, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2022. Included in 40,000 restricted stock units awarded to the Reporting Person on January 17, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on May 23, 2023. Included in 70,000 restricted stock units awarded to the Reporting Person on June 12, 2023, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2023. Included in 110,000 restricted stock units awarded to the Reporting Person on April 26, 2024, pursuant to the Co-Diagnostics, Inc. 2015 Long Term Incentive Plan, and vest in six equal installments every six months commencing on November 23, 2024.